Publications by authors named "Birgit Zucker"

Claim this Profile
S
Substantia nigra hyperechogenicity in hypokinetic Huntington's disease patients.
Johann Lambeck, Wolf-Dirk Niesen, Matthias Reinhard, Cornelius Weiller, Matthias Dose, Birgit Zucker

J Neurol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Substantia nigra hyperechogenicity in hypokinetic Huntington's disease patients.
Johann Lambeck, Wolf-Dirk Niesen, Matthias Reinhard, Cornelius Weiller, Matthias Dose, Birgit Zucker

J Neurol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reelin together with ApoER2 regulates interneuron migration in the olfactory bulb.
Sabine Hellwig, Iris Hack, Birgit Zucker, Bianka Brunne, Dirk Junghans

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analyses of Purkinje cell gene expression profiles reveal shared molecular abnormalities in models of different polyglutamine diseases.
Bernd Friedrich, Philipp Euler, Ruhtraut Ziegler, Alexandre Kuhn, Bernhard G Landwehrmeyer, Birgit Zucker

Brain Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression analysis on a single cell level in Purkinje cells of Huntington's disease transgenic mice.
Philipp Euler, Bernd Friedrich, Ruhtraut Ziegler, Alexandre Kuhn, Katrin S Lindenberg, Birgit Zucker

Neurosci Lett· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington disease.
Birgit Zucker, Jibrin A Kama, Alexandre Kuhn, Doris Thu, Lianna R Orlando

J Neuropathol Exp Neurol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective.
Zhihua Qiu, Fran Norflus, Bhupinder Singh, Mary K Swindell, Rodica Buzescu, Birgit Zucker

J Biol Chem· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1.
Birgit Zucker, Ruth Luthi-Carter, Jibrin A Kama, Anthone W Dunah, Edward A Stern

Hum Mol Genet· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
Jonathan H Fox, David S Barber, Bhupinder Singh, Birgit Zucker, Mary K Swindell

J Neurochem· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease.
Birgit Zucker, Dagmar E Ludin, Thomas A Gerds, Carl H Lücking, G Bernhard Landwehrmeyer

Naunyn Schmiedebergs Arch Pharmacol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice.
Robert J Ferrante, James K Kubilus, Junghee Lee, Hoon Ryu, Ayshe Beesen, Birgit Zucker

J Neurosci· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis